Skip to content
Ransomware

Microbix Biosystems listed by Qilin ransomware group

The Qilin ransomware group has listed Microbix Biosystems on its leak site, alleging a data breach.

By
Siberpol Intelligence Unit
Published
3 min read
3 min read
  • Ransomware group: Qilin
  • Country: Canada
  • Sector: Healthcare
  • Announcement date: October 28, 2025

The Qilin ransomware group has listed the Canadian biotechnology company Microbix Biosystems on its dedicated leak site, alleging that the organization has been the victim of a data breach. This announcement, made on October 28, 2025, marks a significant development for the healthcare-focused entity, as the threat actor claims to have successfully compromised the organization's internal systems.

The alleged attack and claims by Qilin

According to the announcement published by the Qilin ransomware group, the attackers claim to have gained unauthorized access to the systems of Microbix Biosystems. The group asserts that they have obtained various files during their intrusion. While the group has made these claims, the specific details regarding the exact timing of the initial access remain tied to the group's own assertions, which cite a date of June 19, 2025.

Ransomware groups like Qilin often utilize a tactic known as double extortion. In this model, attackers do not merely encrypt an organization's data to disrupt operations; they also exfiltrate sensitive information to use as leverage. The threat of releasing stolen data on a public leak site serves as a powerful tool to pressure the victim into paying a ransom. If the ransom is not met, these groups typically follow through by publishing the stolen information to damage the victim's reputation or force compliance through public exposure.

Scope of the compromised data

The information currently available regarding the specific contents of the breach is limited. The Qilin group has provided screenshots to support their claims, but these images appear to show blurred document samples. These samples resemble internal correspondence or operational records, yet they do not provide a clear or detailed view of the full scope of the data that may have been taken. Consequently, there is no detailed information regarding the total volume of files or the specific categories of data involved beyond the initial observations.

Based on the available evidence, the following types of information are identified as potentially affected:

  • Corporate operational documents

Because the group has not provided specific details regarding the file count or the exact nature of the documents, the full extent of the compromise remains unverified.

Microbix Biosystems profile

Microbix Biosystems is a biotechnology company based in Canada. The organization specializes in the development and manufacture of biological specimens and quality control products intended for use by medical laboratories and manufacturers of diagnostic devices. Their expertise lies in producing reference standards and antigens, which are considered critical components for conducting genetic testing and testing for infectious diseases.

Implications and industry risks

The alleged breach of Microbix Biosystems carries several significant risks due to the nature of the organization's work and its sector. Because the company operates within the healthcare sector, the potential leakage of sensitive information could pose legal risks related to patient privacy and compliance with regulatory frameworks, such as Canada's PIPEDA regulations. Furthermore, the loss of sensitive information could potentially damage the organization's intellectual property rights.

Beyond the immediate corporate impact, such breaches can lead to secondary risks. These include the possibility of identity theft or the execution of targeted phishing attacks aimed at the organization's employees and business partners. When a company's internal correspondence or operational records are compromised, attackers can use that context to craft highly convincing social engineering campaigns.

For organizations operating in the biotechnology and healthcare sectors, maintaining robust cybersecurity postures is essential to mitigate these risks. Common defensive steps often include implementing strict access controls, maintaining regular offline backups, and conducting comprehensive employee training to recognize phishing attempts. Given the history of the Qilin group, which has been active as a Ransomware-as-a-Service (RaaS) entity since 2022, there remains a possibility that the leaked data could be made public or that additional data could be released if the group's demands are not met.

Threat Intelligence

Track ransomware groups, victim posts and indicators of compromise, and see the records that match your own assets.

Related stories